Home
OrbiMed Advisors Israel II, 10% Owner: Damora Therapeutics DMRA Sell · Filed 23/07/17
Trade details
- Type
- Insider sale
- Amount
- $317,040
- Shares · price
- 132,100 sh · $2.40 a share
- Held after
- 2,285,687 sh
- Trade date
- 23/07/13
- Filed
- 23/07/17
- Days to filing
- 4 days
Sold 5.5% of holdings
- Share of holding sold
- 5.5%
Damora Therapeutics trades, last 26 weeks
What else happened in Damora Therapeutics around then
Filed or reported within 30 days of the trade day · 23/06/13~23/08/12OrbiMed Advisors Israel II's recent trades
- OrbiMed Advisors Israel II
BuyADARx Pharmaceuticals
BuyADARx Pharmaceuticals
ADRX
$10M
588,235 sh
$10M
Filed 09/30
Traded 09/28
- OrbiMed Advisors Israel II
BuyADARx Pharmaceuticals
BuyADARx Pharmaceuticals
ADRX
$5.1M
300,249 sh
$5.1M
Filed 09/30
Traded 09/28
- OrbiMed Advisors Israel II
BuyADARx Pharmaceuticals
BuyADARx Pharmaceuticals
ADRX
$1M
61,516 sh
$1M
Filed 09/30
Traded 09/28
- OrbiMed Advisors Israel II
SellAdicet Bio
SellAdicet Bio
ACET
$263.5K
40,416 sh
$263.5K
Filed 04/09
Traded 04/08
- OrbiMed Advisors Israel II
SellAdicet Bio
SellAdicet Bio
ACET
$204.6K
32,523 sh
$204.6K
Filed 04/09
Traded 04/08
